rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Nanobiomaterials in cancer therapy
    sub title: applications of nanobiomaterials
  name:
    name part: Grumezescu, Alexandru Mihai
    role:
      role term: editor.
  name:
    name part: ScienceDirect (Online service)
  type of resource: text
  genre: bibliography
  genre: Electronic books.
  origin info:
    place:
      place term: enk
    date issued: 2016
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource
  abstract: Nanobiomaterials in Cancer Therapy presents the major applications of nanobiomaterials in oncology, offering an up-to-date overview of the latest research in this field. Utilizing nanobiomaterials, novel therapeutic approaches enable significant improvements in drug-loading capacity, formulation stability and drug efficiency. In this book, leading researchers from around the world share their expertise and unique insights. The book covers the fabrication methods of platforms for multimodal and combinatorial therapeutic options, along with simultaneous and real-time cancer imaging, and innovative approaches for oncology by passive or active pathways of multifunctional nanocarriers. The work also classifies and discusses engineered nanobiosystems for cancer therapy, prevention, and low cancer recurrence or relapse. This book will be of interest to postdoctoral researchers, professors and students engaged in the fields of materials science, biotechnology and applied chemistry. It will also be highly valuable to those working in industry, including pharmaceutics and biotechnology companies, medical researchers, biomedical engineers and advanced clinicians.
  table of contents: Front Cover; Nanobiomaterials in Cancer Therapy; Copyright Page; Contents; List of contributors; Preface of the series; Preface; About the Series (Volumes I-XI); About Volume VII; 1 Nanopreparations for skin cancer therapy; 1.1 Introduction; 1.2 Skin Morphology; 1.3 Types of Cancer; 1.4 Non-Melanoma Skin Cancer; 1.5 Melanoma Skin Cancer; 1.6 Penetration Pathways of Skin; 1.7 Drug Delivery Systems Applied to Skin Cancer Treatment; 1.8 Liposomes; 1.9 Nanoemulsions and Nanosuspensions; 1.10 Polymeric Nanoparticles; 1.11 Lipid Nanoparticles; 1.12 Dendrimers; 1.13 Photodynamic Therapy
  table of contents: 1.14 ConclusionsReferences; 2 Silver nanoparticles in cancer therapy; 2.1 Introduction; 2.2 Silver Nanoparticles; 2.3 Synthesis; 2.3.1 Chemical Synthesis; 2.3.2 Physical Synthesis; 2.3.3 Biological Synthesis; 2.3.3.1 Silver nanoparticles synthesized by bacteria; 2.3.3.2 Silver nanoparticles synthesized by fungi; 2.3.3.3 Silver nanoparticles synthesized by plants; 2.4 Shape; 2.5 Silver Nanoparticles-Cancer Diagnosis and Treatment Applications; 2.5.1 Leukemia; 2.5.2 Breast Cancer; 2.5.3 Lung Cancer; 2.5.4 Prostate Cancer; 2.5.5 Hepatic Cancer; 2.5.6 Cervical Cancer; 2.5.7 Skin Cancer
  table of contents: 2.5.8 Larynx Cancer2.5.9 Colon Cancer; 2.6 Conclusions; References; 3 Nanobiomaterials in cancer therapy; 3.1 Introduction; 3.2 The Enhanced Permeability and Retention (EPR) Effect; 3.3 Nanomaterials in Cancer Therapy; 3.3.1 Inorganic NPs; 3.3.1.1 Quantum dots; 3.3.1.2 Magnetic NPs; 3.3.2 Organic NPs; 3.3.2.1 Liposomes; 3.3.2.2 Polymeric micelles; 3.3.2.3 Dendrimers; 3.4 Chemotherapy-Based Nanoformulations; 3.4.1 Doxorubicin; 3.4.2 Paclitaxel; 3.4.3 Cisplatin; 3.4.4 Docetaxel; 3.4.5 Nanotetrac; 3.5 Multifunctional NPs; 3.5.1 Delivery of siRNA and shRNA Complexes; 3.5.2 Active Targeting
  table of contents: 3.6 Cancer Therapy Using Natural Products: Nanochemoprevention3.6.1 EGCG; 3.6.2 Resveratrol; 3.6.3 Curcumin; 3.7 Cancer Stem Cells: A Nanotechnology Perspective; 3.8 Conclusions; References; 4 Advances in nanobiomaterials for oncology nanomedicine; 4.1 Introduction; 4.2 Organic Nanobiomaterials; 4.2.1 Liposomes; 4.2.2 Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC); 4.2.3 Polymeric Nanocapsules and Nanospheres; 4.3 Inorganic Nanobiomaterials; 4.3.1 Mesoporous Silica Nanoparticles (MSNs); 4.3.2 Spherical Nucleic Acid Nanoparticles (SNA-NPs)
  table of contents: 4.3.3 Boron Nitride Nanotubes (BNNTs)4.4 Combination of Nanotechnology with Photodynamic Therapy to Improve Cancer Treatment; 4.5 Toxicity and Risk Management; 4.6 Conclusions; Acknowledgments; References; 5 Nanobiomaterials: Emerging platform in cancer theranostics; 5.1 Introduction; 5.2 Theranostics and Nanomedicine; 5.2.1 Gold Nanoparticles; 5.2.2 Iron Oxide Nanoparticles in Cancer Theranostics; 5.2.3 Superparamagnetic Iron Oxide Nanoparticles; 5.2.4 Carbon Nanotubes; 5.2.5 Quantum Dots; 5.2.6 Dendrimers; 5.2.7 Vesicular Systems; 5.2.7.1 Liposomes; 5.2.7.2 Polymerosomes
  note: edited by Alexandru Mihai Grumezescu.
  note: Includes bibliographical references and index.
  subject:
    topic: Nanomedicine
  subject:
    topic: Cancer
    topic: Treatment
  subject:
    topic: Nanobiotechnology
  subject:
    topic: Biomedical materials
  subject:
    topic: Nanomedicine
  subject:
    topic: Cancer
    topic: Traitement
  subject:
    topic: Nanobiotechnologie
  subject:
    topic: Biomatériaux
  subject:
    topic: Nanomédecine
  subject:
    topic: HEALTH & FITNESS
    topic: Holism
  subject:
    topic: HEALTH & FITNESS
    topic: Reference
  subject:
    topic: MEDICAL
    topic: Alternative Medicine
  subject:
    topic: MEDICAL
    topic: Atlases
  subject:
    topic: MEDICAL
    topic: Essays
  subject:
    topic: MEDICAL
    topic: Family & General Practice
  subject:
    topic: MEDICAL
    topic: Holistic Medicine
  subject:
    topic: MEDICAL
    topic: Osteopathy
  subject:
    topic: Biomedical materials
  subject:
    topic: Cancer
    topic: Treatment
  subject:
    topic: Nanobiotechnology
  subject:
    topic: Nanomedicine
  classification: R857.N34
  classification: 610.28
  related item:
    title info:
      title: Applications of nanobiomaterials ; volume 7
  related item:
    title info:
      title: Nanobiomaterials in cancer therapy
    origin info:
      publisher: Oxford : William Andrew, an imprint of Elsevier, 2016
    identifier: (OCoLC)932174426
  identifier: 9780323428866
  identifier: 032342886X
  identifier: 9780323428637
  identifier: 0323428630
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: OPELS
    record creation date: 160329
    record change date: 20260407211045.6
    record identifier: in00005760150
    language of cataloging:
      language term: eng